SOURCE: Research and Markets

Research and Markets

February 17, 2016 07:27 ET

Global Biotherapeutics Market Report -- Analysis, Technologies & Forecast Report 2016 -- Key Vendors: 4P Therapeutics, Endo International & FluGen

DUBLIN, IRELAND--(Marketwired - February 17, 2016) - Research and Markets has announced the addition of the "Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)" report to their offering.

This new report provides a comprehensive analysis of the current market landscape and the future outlook of technologies focused on the formulation and delivery of biotherapeutics, primarily proteins and antibodies.

Biopharmaceuticals has become an area of heavy interest for many pharmaceutical companies; they make up about one-third of all the drugs that are currently in development. The industry is growing at a healthy pace resulting in a substantial shift from conventional chemical synthesis to biotechnological processes in the way drugs are now produced.

Intravenous (IV) route has been the most popular route for administering large molecule drugs such as proteins and antibodies. However, with the rising popularity of biologics and biosimilars, several companies are now looking forward to technologies that can be used for delivering biotherapeutics via a route other than IV injection or infusion.

Technologies focused on oral, SC and transdermal routes are becoming more popular and, therefore, are expected to be the major contributors to the overall drug delivery technologies market. In addition, there are other novel targeted approaches, such as bypassing blood brain barrier, which are likely to change the industry paradigm in the long run.

Companies Mentioned Include:

  • 4P Therapeutics
  • Endo International
  • Entrega Bio
  • Essex Woodlands Health Ventures
  • ExcelseBio
  • Exeter University
  • Extend Biotechnology
  • Fletcher Spaght Ventures
  • FluGen
  • Fredric Price
  • GALVmed
  • GSK
  • Galena Biopharma
  • GenBiotech
  • Genentech
  • Generex Biotechnology
  • Generium
  • Genta
  • Genzyme
  • Geron
  • GlaxoSmithKline
  • Glide Healthcare Partners
  • Golden Seeds
  • Jerusalem Global Ventures
  • Johnson and Johnson
  • Medpace
  • Merck
  • Merlin Biosciences
  • Merrion Pharmaceuticals
  • Midatech Group

Report Structure:

1. Preface

2. Executive Summary

3. Biopharmaceuticals: An Introduction

4. Market Overview

5. Key Oral Formulationand Delivery Platforms

6. Key Subcutaneous Formulation And Delivery Platforms

7. Key Dermal Formulation And Delivery Platforms

8. Other Formulation And Delivery Platforms

9. Recent Partnerships/Collaborations

10. Venture Capital Interest

11. Market Forecast

12. SWOT Analysis

13. Interview Transcripts

For more information visit http://www.researchandmarkets.com/research/dn67zr/biotherapeutics

Sector: Biopharmaceuticals

Image Available: http://www.marketwire.com/library/MwGo/2016/2/17/11G083240/Images/biotherapeutics_novel_formulation_and_delivery-e5f9c6a9afaa9b629a7f614cd7a4adc5.jpg

Contact Information

  • Research and Markets
    Laura Wood
    Senior Manager
    press@researchandmarkets.com

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716